Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,047,125
-
Share change
-
+726,360
-
Total reported value
-
$20,049,463
-
Put/Call ratio
-
76%
-
Price per share
-
$9.77
-
Number of holders
-
33
-
Value change
-
+$7,527,325
-
Number of buys
-
22
-
Number of sells
-
10
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q1 2025
As of 31 Mar 2025,
Nuvectis Pharma, Inc. - COM (NVCT) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,047,125 shares.
The largest 10 holders included
VANGUARD GROUP INC, BALDWIN WEALTH PARTNERS LLC/MA, IRIDIAN ASSET MANAGEMENT LLC/CT, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, UBS Group AG, BlackRock, Inc., FORBES J M & CO LLP, GOLDMAN SACHS GROUP INC, and JANE STREET GROUP, LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.